rxstatShortages › Alteplase

Alteplase shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Alteplase has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 1
Reports on file
2

Reports by product

Resolved
CATHFLO
2MG · POWDER FOR SOLUTION · HOFFMANN-LA ROCHE LIMITED
DIN 02245859 · ended Mar 4, 2025 · Requirements related to complying with good manufacturing practices.
Avoided
CATHFLO
2MG · POWDER FOR SOLUTION · HOFFMANN-LA ROCHE LIMITED
DIN 02245859 · ended Sep 30, 2024 · Requirements related to complying with good manufacturing practices.

What's happening

There are no active shortage reports for Alteplase. Health Canada has 2 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Alteplase is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AD).

Recent changes

Common questions

When will Alteplase be back in stock in Canada?

Alteplase has no active shortage; supply is normal per Health Canada reports.

Why is Alteplase in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antithrombotic agents)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.